Financial issues

At the time of a blood cancer diagnosis, your first and main thought should be your wellbeing. But sometimes, financial issues can also be a worry and you may need help to cope with this.

A cancer diagnosis can affect many aspects of your life including your finances. This section will help provide information and advice on the practical issues you may need to consider after diagnosis and during treatment.

Money and benefits

A cancer diagnosis can affect many aspects of your life including your finances, working arrangements and travel. This section will help provide information and advice on the practical issues you may need to consider after diagnosis and during treatment.

Welfare benefits

We talk you through state benefits, eligibility and more. It's important to note that the purpose of this webpage is to give an overview of the benefits that may be relevant to you as a leukaemia patient. Speak to our Advocacy team for guidance on personal claims.

Our Hospital Hubs

Our Hospital Hubs are the perfect place for you or your loved ones to meet with a member of the Leukaemia Care team for advice, support or simply a chat.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

December 4th

How the Budget News Affects You, and Why We’ll Continue to Push for Change

It’s been around two weeks since the Chancellor of the Exchequer announced his Autumn Statement, setting out the spending priorities of the Government. In this blog, our Policy and Evidence Manager, Charlotte Crowley, reflects on the announcements and their impact on you. ...

October 31st

October Fundraising: Highlighting our community

With spooky season in full effect, we want to share some of the fang-tastic fundraising you have done this October in support of those living with Leukaemia....

October 20th

Leukaemia Care successfully campaigns for nationwide access to new chronic lymphocytic leukaemia treatment

The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) have announced the approval of zanubrutinib on the NHS for patients with chronic lymphocytic leukaemia (CLL) in all nations of the UK....